Category: News
Melanoma Research Updates from 2020 AACR and ASCO Conferences
By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 29 June 2020 In News, Science, Treatment
MRA Chief Science Officer Marc Hurlbert shares exciting melanoma research highlights from ASCO and AACR - the two largest global cancer research conferences that take place annually.
Maintaining Momentum in Melanoma Research
8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment
The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.
Putting Healthy Skin First - L’Oréal Active Cosmetics Division & MRA Strengthen Longstanding L’Oréal and MRA Partnership
By Cody R. Barnett, MRA Director of Communications | 1 May 2020 In Allies & Partnerships, News, Science
Some partnerships just make sense. For example, L’Oréal-owned SkinCeuticals, CeraVe and La Roche-Posay apart of the L’Oreal Active Cosmetics Division and MRA both share a mission and ethos for promoting healthy skin. It is no surprise that the two are longtime partners in the fight against melanoma. In fact, these brands and MRA have just announced an expanded partnership just in time for Melanoma Awareness Month.
MRA Announces $11 Million for 26 Grant Awards to Advance Melanoma Research
By Cody R. Barnett, MRA Director of Communications | 30 April 2020 In News, Science
With the world’s attention focused on the response to COVID-19, the Melanoma Research Alliance (MRA) knows that long after this pandemic has ended, melanoma research will still be urgently needed. To this end, and in recognition of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, is proud to announce funding for 26 research awards totaling $10.9 million.
Coronavirus: What People with Cancer Should Know
24 March 2020 In News, Policy, Science, Treatment
Coronaviruses are a large family of viruses that are common in people and many different species of animals. CDC is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and has now been detected in the United States and many other countries.
2020 Melanoma Mortality Rates Decreasing Despite Ongoing Increase in Incidence
By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 9 January 2020 In News, Prevention, Science, Treatment
Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for...
Highlights from the 2019 Scientific Retreat
30 May 2019 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Over the course of three days, MRA convened over 300 people from across the melanoma research community: patients, doctors, researchers, industry, and government. Participants discussed everything from new treatment approaches such as RNA-based vaccines, strategies to fight back against treatment resistance, and hurdles to testing neo-adjuvant therapies in melanoma.
Research is Hope: MRA Announces $8.2 Million for New Grant Awards to Advance Melanoma Research
By Cody R. Barnett, MRA Director of Communications | 30 April 2019 In News, Science
In advance of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today announced funding for 33 innovative research awards totaling $8.26 million.
Fight Back Give Back with Clinical Trials
By Cody R. Barnett, MRA Director of Communications | 24 February 2019 In News, Science
When patients understand all of their options, including clinical trials, they can make informed decisions about their care. For many patients, clinical trials represent the best possible way to get access to cutting-edge treatment options.
MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care
By Cody R. Barnett, MRA Director of Communications | 28 November 2018 In News, Science, Treatment
MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.